Philips provides periodic update on its share repurchases and announces completion of cancellation of shares

December 16, 2016

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported the transaction details related to the repurchases of its own common shares made in the period from December 9, 2016 up to and including December 15, 2016.

 

These repurchases were made under the repurchase program to cover long term incentive and employee share purchase plans. Further details can be found in the table below and via this link.

Date
Total number of repurchased shares
Weighted average purchased price (EUR)
December 9, 2016
30,000
27.7828
December 12, 2016
85,000
27.7189
December 13, 2016
120,000
28.1195
December 14, 2016
40,000
28.0088
December 15, 2016
25,000
28.2581

In addition, Philips has completed the cancellation of 18,829,985 of its shares. The cancelled shares were acquired from November 21, 2015, up to and including October 20, 2016, as part of Philips’ EUR 1.5 billion share repurchase program that started on October 21, 2013, and was completed in October 2016. The average repurchase price of the cancelled shares was EUR 23.89 per share.

 

Currently, Philips’ issued share capital amounts to 929,644,864 shares. 

For further information, please contact:

Ben Zwirs

Philips Group Communications

Tel.: +31 6 15213446

E-mail: ben.zwirs@philips.com

 

Vanessa Bruinsma-Kleijkers

Philips Investor Relations

Tel.: +31 20 5977447

E-mail: investor.relations@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.